Given that the pons and hypothalamus are both key parts of controlling food intake and energy metabolism [36], the above data shows that PrRP-GPR10 should play a key role in neuroendocrine metabolism and may even be a potential target for anti-obesity therapy [29,37,38]. The gene discussed is PRLH; the disease is obesity disorder.